Nano-analysis Reveals High Fraction of Serotonin Release during Exocytosis from a Gut Epithelium Model Cell

Angew Chem Int Ed Engl. 2021 Oct 25;60(44):23552-23556. doi: 10.1002/anie.202108193. Epub 2021 Sep 24.

Abstract

Electrochemical methods were used to explore the exocytotic nature of serotonin (5-HT) release in human carcinoid BON cells, an in vitro human enterochromaffin cell model, to understand the mechanisms operating the release of gut-derived 5-HT in the intestinal mucosal epithelium. We show that the fractional vesicular 5-HT release in BON cells is 80 % compared to previous work in pancreatic beta cells (34 %). The fractional release increased from 80 % in control BON cells to 87 % with 5-HT preincubation and nearly 100 % with the combination of 5-HT and the 5-HT4 autoreceptor agonist, cisapride. Thus, partial release is the primary mechanism of exocytosis in BON cells, resulting in a variable amount of the vesicular content being released. Factors that control secretion of 5-HT from enterochromaffin cells or BON cells are important as partial release provides a mechanism for development of effective therapeutic strategies to treat gastrointestinal diseases.

Keywords: BON cells; exocytosis; gut-derived 5-HT; nano-analysis; partial release.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Drug Liberation
  • Electrochemical Techniques*
  • Enterochromaffin Cells / drug effects*
  • Exocytosis / drug effects
  • Gastrointestinal Diseases / drug therapy
  • Humans
  • Nanotechnology*
  • Serotonin / chemistry
  • Serotonin / pharmacology*

Substances

  • Serotonin